Business
Press Release Oct 11 2021
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 11, 2021, titled "Glenmark launches Tavulus�� for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 11, 2021, titled \"Glenmark launches Tavulus�� for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler\". View Attachment","length":423,"tagName":"div"}]